The Interest of Cancer Patients and Caregivers in Acupuncture: a Survey (ACTIVATE)

February 20, 2019 updated by: Dr. Philip Debruyne, General Hospital Groeninge
Cancer and cancer treatments are accompanied by several possible side effects, such as nausea, hot flashes, fatigue, drowsiness, etc. Complementary and integrative therapies, such as acupuncture, could be used to manage these symptoms. The aim of this study for our research team is to have an idea of the interest of cancer patients and caregivers in acupuncture. This is a prospective, interventional study. Cancer patients and caregivers will be approached at the day care clinic by a health care worker to participate in this study. They will be asked to complete a questionnaire about their interest in acupuncture and their motivation, what symptoms they would need it for, where they would like this acupuncture to take place, whether they are willing to pay for it, and whether they would be interested in an information session about acupuncture.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Kortrijk, Belgium, 8500
        • General Hospital Groeninge, Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Dutch speaking patients and caregivers
  • Patients and caregivers presenting at the outpatient clinic, including the day-care clinic and follow up visits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Intervention
Patients and caregivers are asked to complete a questionnaire
Other: Questionnaire
Patients and caregivers are asked to complete a questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Response rate
Time Frame: At study inclusion
At study inclusion

Secondary Outcome Measures

Outcome Measure
Time Frame
Interest in acupuncture assessed by questionnaire
Time Frame: At study inclusion
At study inclusion
Side effects participants would like to receive acupuncture for assessed by questionnaire
Time Frame: At study inclusion
At study inclusion
Place where an acupuncture treatment should take place assessed by questionnaire
Time Frame: At study inclusion
At study inclusion
Willingness to pay for an acupuncture treatment assessed by questionnaire
Time Frame: At study inclusion
At study inclusion
Interest in an information session about acupuncture assessed by questionnaire
Time Frame: At study inclusion
At study inclusion
Patient or caregiver characteristics (sex, age, diagnosis) collected by questionnaire
Time Frame: At study inclusion
At study inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

General Hospital Groeninge

Investigators

  • Principal Investigator: Philip Debruyne, MD, PhD, MSc, FRCP, General Hospital Groeninge

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2018

Primary Completion (Actual)

November 26, 2018

Study Completion (Actual)

November 27, 2018

Study Registration Dates

First Submitted

November 14, 2018

First Submitted That Met QC Criteria

November 14, 2018

First Posted (Actual)

November 16, 2018

Study Record Updates

Last Update Posted (Actual)

February 22, 2019

Last Update Submitted That Met QC Criteria

February 20, 2019

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AZGS2018093

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe